Inhaled Treatment for Asthma and COPD Market Size is USD 11.42 Billion by 2025

Inhaled Treatment for Asthma and COPD Market (By Type: Inhaled Corticosteroids, Long-acting Bronchodilators, Short-acting Bronchodilators, Combination Medications, and Others; By Application: Hospital, Clinic, and Others; By Region: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Industry Size, Share, Growth, Trends 2025 to 2034.

Stats ID: 8756 | Delivery Format: Databook | Tables and Figures: 33+ | Last Updated: September 2025 | Delivery: Immediate

The global inhaled treatment for asthma and COPD market, valued at USD 11.01 billion in 2024, is projected to reach USD 15.84 billion by 2034, growing at a 3.7% CAGR as advancements in respiratory therapies and patient demand for effective treatments increase.

Inhaled Treatment for Asthma and COPD Market Statical Scope

Reports Attributes	Statistics
Market Size in 2024	USD 11.01 Billion
Market Size in 2025	USD 11.42 Billion
Market Size in 2031	USD 14.2 Billion
Market Size by 2034	USD 15.84 Billion
CAGR 2025 to 2034	3.7%
Base Year	2024
Forecast Period	2025 to 2034

Inhaled Treatment for Asthma and COPD Market Companies

Boehringer Ingelheim
GSK
Teva Pharmaceutical
Prasco Laboratories
Cipla
Lupin Laboratories
Laboratorio Aldo-Union
Polpharma
Novartis
The Menarini Group
Covis Pharma
Zentiva
Alfasigma
Gebro-Pharma
Kohl Medical
Sumitomo Pharma
Chiesi Farmaceutici
Glenmark Pharmaceuticals
Orion Corporation
Bausch Health
Viatris
AstraZeneca
LEK-AM
Adamed Group
STADA Arzneimittel
Organon
Anhui Wellman Pharmaceutical
Zhejiang Xianjun Pharmaceutical
Chia Tai Tianqing Pharmaceutical Group
Nanchang Helioeast Technology
Jewim Pharmaceutical
Heilongjiang Fulekang Pharmaceutical
Shanghai Pharmaceuticals
Lunan Better Pharmaceutical
China Resources Double Crane Pharmaceutical

Inhaled Treatment for Asthma and COPD Market Segmentation

By Type

Inhaled Corticosteroids
Long-acting Bronchodilators
Short-acting Bronchodilators
Combination Medications
Others

By Application

Hospital
Clinic
Others

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Published by Rohan Patil

Global Market Revenue

Inhaled Treatment for Asthma and COPD Market Revenue, By Type 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Inhaled Corticosteroids	3.31	3.40	3.51	3.62	3.71	3.83	3.94	4.06	4.17	4.31	4.43
Long-acting Bronchodilators	2.75	2.88	3.01	3.14	3.28	3.43	3.59	3.75	3.92	4.09	4.28
Short-acting Bronchodilators	1.65	1.68	1.70	1.73	1.76	1.78	1.81	1.83	1.86	1.88	1.90
Combination Medications	2.75	2.89	3.03	3.18	3.34	3.50	3.67	3.85	4.03	4.23	4.43
Others	0.55	0.57	0.59	0.61	0.64	0.66	0.68	0.71	0.74	0.76	0.79

Inhaled Treatment for Asthma and COPD Market Revenue, By Application 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospital	3.85	3.96	4.07	4.19	4.30	4.42	4.55	4.67	4.80	4.93	5.07
Clinic	6.06	6.30	6.54	6.79	7.05	7.33	7.61	7.91	8.21	8.54	8.86
Others	1.10	1.16	1.23	1.30	1.38	1.45	1.53	1.62	1.71	1.80	1.90

Inhaled Treatment for Asthma and COPD Market Revenue, By Region 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
North America	3.86	3.97	4.11	4.22	4.36	4.49	4.63	4.77	4.92	5.07	5.22
Asia Pacific	2.75	2.90	3.05	3.22	3.39	3.56	3.75	3.95	4.15	4.37	4.59
Europe	3.08	3.16	3.24	3.33	3.41	3.50	3.59	3.68	3.77	3.86	3.96
Latin America	0.66	0.70	0.73	0.77	0.81	0.86	0.90	0.95	1	1.05	1.11
Middle East and Africa	0.66	0.69	0.71	0.74	0.76	0.79	0.82	0.85	0.88	0.92	0.95

Global Market Revenue

Inhaled Treatment for Asthma and COPD Market Revenue, By Type 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Inhaled Corticosteroids	3.31	3.40	3.51	3.62	3.71	3.83	3.94	4.06	4.17	4.31	4.43
Long-acting Bronchodilators	2.75	2.88	3.01	3.14	3.28	3.43	3.59	3.75	3.92	4.09	4.28
Short-acting Bronchodilators	1.65	1.68	1.70	1.73	1.76	1.78	1.81	1.83	1.86	1.88	1.90
Combination Medications	2.75	2.89	3.03	3.18	3.34	3.50	3.67	3.85	4.03	4.23	4.43
Others	0.55	0.57	0.59	0.61	0.64	0.66	0.68	0.71	0.74	0.76	0.79

Inhaled Treatment for Asthma and COPD Market Revenue, By Application 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospital	3.85	3.96	4.07	4.19	4.30	4.42	4.55	4.67	4.80	4.93	5.07
Clinic	6.06	6.30	6.54	6.79	7.05	7.33	7.61	7.91	8.21	8.54	8.86
Others	1.10	1.16	1.23	1.30	1.38	1.45	1.53	1.62	1.71	1.80	1.90

Inhaled Treatment for Asthma and COPD Market Revenue, By Region 2024 to 2034 (USD Billion)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
North America	3.86	3.97	4.11	4.22	4.36	4.49	4.63	4.77	4.92	5.07	5.22
Asia Pacific	2.75	2.90	3.05	3.22	3.39	3.56	3.75	3.95	4.15	4.37	4.59
Europe	3.08	3.16	3.24	3.33	3.41	3.50	3.59	3.68	3.77	3.86	3.96
Latin America	0.66	0.70	0.73	0.77	0.81	0.86	0.90	0.95	1	1.05	1.11
Middle East and Africa	0.66	0.69	0.71	0.74	0.76	0.79	0.82	0.85	0.88	0.92	0.95

Download PDF Help Center

Proceed to Buy

Databook:

$1550

Deep Dive Analysis:

$1950

Customize this Report

The report offers key market data-from trends to estimates and forecasts-customizable for strategic planning.

Customize Request

Schedule Meeting

Inhaled Treatment for Asthma and COPD Market Size is USD 11.42 Billion by 2025

Inhaled Treatment for Asthma and COPD Market Statical Scope

Inhaled Treatment for Asthma and COPD Market Companies

Inhaled Treatment for Asthma and COPD Market Segmentation

By Type

By Application

By Region

Global Market Revenue

Inhaled Treatment for Asthma and COPD Market Revenue, By Type 2024 to 2034 (USD Billion)

Inhaled Treatment for Asthma and COPD Market Revenue, By Application 2024 to 2034 (USD Billion)

Inhaled Treatment for Asthma and COPD Market Revenue, By Region 2024 to 2034 (USD Billion)

Global Market Revenue

Inhaled Treatment for Asthma and COPD Market Revenue, By Type 2024 to 2034 (USD Billion)

Inhaled Treatment for Asthma and COPD Market Revenue, By Application 2024 to 2034 (USD Billion)

Inhaled Treatment for Asthma and COPD Market Revenue, By Region 2024 to 2034 (USD Billion)

Proceed to Buy

Customize this Report

The report offers key market data-from trends to estimates and forecasts-customizable for strategic planning.

Download Databook

Bis(2,2,6,6-tetramethyl-3,5-heptanedionato)Barium Tetraglyme Adduct Market

Art and Craft Material - Worldwide

Meningococcal Vaccines - Worldwide